Total: 4 |
|
PMID (PMCID) | ||
---|---|---|
30009125 (6038051) |
OTHER | |
Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage. | ||
Noda Y, Saka Y, Kato A, Mimura T, Naruse T. Clin Nephrol Case Stud. 2018;6:16-20. |
||
Thrombocytopenia, anasarca, fever, renal insufficiency, and organomegaly constitute TAFRO syndrome, a variant of Castleman disease. | ||
23917782 |
MALE | Middle Aged |
Widespread hypermetabolic lesions due to multicentric form of Castleman disease as the cause of fever of unknown origin revealed by FDG PET/CT. | ||
Ma Y, Li F, Chen L. Clin Nucl Med. 2013;38(10):835-7. |
||
Widespread hypermetabolic lesions due to multicentric form of Castleman disease as the cause of fever of unknown origin revealed by FDG PET/CT. | ||
22954613 |
MALE | Adult |
FDG-PET imaging in the diagnosis of HIV-associated multicentric Castleman disease: something is still missing. | ||
Rossotti R, Moioli C, Schiantarelli C, Orcese C, Puoti M. Top Antivir Med. 2012;20(3):116-8. |
||
In clinical practice, FDG-PET has been proposed to assess fever of unknown origin or with lymphoproliferative disorders such as Castleman disease in individuals with HIV infection. | ||
16922487 |
MALE | Middle Aged |
[A case of HIV-1 and HHV-8-associated Castleman disease with a relapsing high fever and lymphoadenopathy]. | ||
Minami R, Yamamoto M. Kansenshogaku Zasshi. 2006;80(4):423-7. |
||
[A case of HIV-1 and HHV-8-associated Castleman disease with a relapsing high fever and lymphoadenopathy]. |